AdvisorShares Psychedelics ETF (PSIL) Holdings $11.91 -0.10 (-0.83%) (As of 11/21/2024 ET) Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatings Top 27 PSIL HoldingsRankCompanyCurrent PriceWeightShares Held1Treasury Trust FundN/A11.62%734,8812MNMDMind Medicine (MindMed)$7.04-6.4%9.32%97,3413Cybin Inc.N/A7.60%47,5414NRXPNRx Pharmaceuticals$1.23+1.7%6.08%291,2715IXHLIncannex Healthcare$1.96-6.2%5.54%142,5456GHRSGH Research$9.62-12.1%5.41%42,797 Get the Latest News and Ratings for PSIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. 7ALKSAlkermes$27.79-0.4%5.20%12,3678Quantum BioPharma Ltd Ordinary Shares - Class B (Sub Voting)N/A5.18%70,8989RLMDRelmada Therapeutics$2.75-3.5%5.03%93,07710CMPSCOMPASS Pathways$4.47-4.3%5.02%67,87711ATAIAtai Life Sciences$1.52-5.0%4.99%292,37012CMNDClearmind Medicine$1.34-1.5%4.87%213,76413SAGESage Therapeutics$4.85-1.2%4.74%51,60514ITCIIntra-Cellular Therapies$85.45-0.2%4.68%3,43315ENVBEnveric Biosciences$0.34-2.9%4.61%628,30716VTGNVistagen Therapeutics$2.54-2.7%4.56%89,58317SEELSeelos Therapeutics$0.38+8.6%2.22%152,44418PBMPsyence Biomedical$0.052.04%1,895,48219Numinus Wellness Inc.N/A0.78%2,418,77620Greenbrook TMS Inc.N/A0.28%1,036,31721Bright Minds Biosciences Inc.N/A0.24%29722CashN/A0.00%423Celly NutritionN/A0.00%263,23624Field Trip Health & Wellness Ltd Ordinary SharesN/A0.00%1,058,41525Lucy Scientific Discovery Inc.N/A0.00%106,69226PsyBio Therapeutics Corp Ordinary SharesN/A0.00%2,994,81727U.S. DollarN/A0.00%1 Geographic ExposureUnited States49.5%Ireland12.7%Canada11.8%Netherlands7.2%Currency ExposureUSD99.3%CAD1.4%Sector ExposureHealth Care15.3%Industry ExposureBiotechnology15.3%SubIndustry ExposureBiotechnology15.3%Coupon Exposure4-610.7% Related Companies and Tools Related Companies TEKX Portfolio NBCC Portfolio FFND Portfolio PSWD Portfolio AGIX Portfolio ESIX Portfolio DAT Portfolio WRND Portfolio CLDL Portfolio IBAT Portfolio This page (NYSEARCA:PSIL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
